Digital pharma: identifying the likely drivers and dangers in a technological revolution that could transform health care

1 December 2016

It is no longer a question of if a digital revolution will happen in health care; it has.

Neither is there any doubt in the industry that this revolution will be the key to making precision medicine a reality, with Steve Jobs’ prediction that the biggest innovations of the 21st century will be at the intersection of biology and technology now a widely accepted claim.

Talk of when the revolution might happen no longer seems relevant, because it has already started. Barely a day goes by when there is not an announcement involving a new technology-led innovation in health care, or a collaboration between pharma and a tech company.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK